Yubo International Biotech Ltd Ordinary Shares - Class A YBGJ
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.96
- Day Range
- $0.57–0.95
- 52-Week Range
- $0.07–1.04
- Bid/Ask
- $0.57 / $0.96
- Market Cap
- $113.83 Mil
- Volume/Avg
- 270 / 2,799
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 188.23
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Yubo International Biotech Ltd is a technology company focused on the research and development and application of endometrial stem cells. It offers products and services under the brand VIVCELL. Its product offerings include healthcare products for the respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products. It also offers stem cell-related services including cell testing and health management consulting services. The company derives its revenue from the sale of certain health management services and the sale of nebulizers containing frozen tubes with medical fluid. The nebulizers are sold directly to consumers on its online e-commerce platform.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- —
- Total Number of Employees
- 18
- Website
- http://www.yubogroup.com
Valuation
|
Metric
|
YBGJ
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 188.23 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
YBGJ
|
|---|---|
Quick Ratio | 0.11 |
Current Ratio | 0.21 |
Interest Coverage | −3,168.98 |
Quick Ratio
YBGJ
Profitability
|
Metric
|
YBGJ
|
|---|---|
Return on Assets (Normalized) | −59.79% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
YBGJ
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Wsbwpbfpg | Nrtzs | $132.1 Bil | |
BDX
| Becton Dickinson & Co | Nydcttvd | Ylxjqy | $67.4 Bil | |
ALC
| Alcon Inc | Xrlvwgj | Hcfffvf | $39.1 Bil | |
CLPBY
| Coloplast A/S ADR | Wqkhcvvmnr | Tby | $28.8 Bil | |
WST
| West Pharmaceutical Services Inc | Fjhklcsjh | Xlbj | $27.6 Bil | |
RMD
| ResMed Inc | Ftxrssylp | Mmnjm | $26.1 Bil | |
BAX
| Baxter International Inc | Xjyxnsks | Vzmyjy | $20.1 Bil | |
COO
| The Cooper Companies Inc | Dnqllkmlt | Jkqxzvw | $18.0 Bil | |
HOLX
| Hologic Inc | Lwrggbtcl | Rsmyhnj | $17.6 Bil | |
TFX
| Teleflex Inc | Sysy | Lwssb | $9.8 Bil |